Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Êàðäèîëîãèÿ > Èíòåðâåíöèîííàÿ êàðäèîëîãèÿ è àíãèîëîãèÿ - ôîðóì äëÿ âðà÷åé

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 08.10.2010, 11:30
rsp rsp âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 17.12.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 686
Ïîáëàãîäàðèëè 58 ðàç(à) çà 51 ñîîáùåíèé
rsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óñòðîéñòâà äëÿ çàêðûòèÿ àðòåðèàëüíîãî äîñòóïà

 ïðåääâåðèè ïîÿâëåíèÿ ñîãëàøåíèÿ ïî ýòèì "÷óäî-óñòðîéñòâàì"
(AHA Statement Offers Guidance on Arterial Closure Device Use) óæå ïîÿâèëèñü [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]. Æäåì âûõîäà ïîëíîòåêñòîâîé âåðñèè.

While the use of arterial closure devices after cardiac catheterization may improve patient comfort, they should not be used routinely to reduce vascular complications since the jury is still out on whether these devices actually accomplish that, according to a new scientific statement from the American Heart Association (AHA) published online October 4, 2010, ahead of print in Circulation.

Öèòàòà:
After weighing the current evidence on closure devices, the authors offer several additional recommendations:
- Patients who are potential candidates for closure devices during femoral access should undergo a femoral angiogram to identify the sheath-insertion site and other features such as atherosclerosis and calcification to ensure anatomic suitability (Class I; Level of Evidence C)
- Centers using standard manual compression regimens should aim to achieve vascular complications rates below 1% in patients undergoing uncomplicated 5 Fr diagnostic angiography (Class I; Level of Evidence C)
- Use of closure devices is “reasonable” after PCI performed via the femoral artery as a means to achieve faster hemostasis and shorter duration of bed rest, and possibly increase patient comfort. But the risk/benefit equation should take into account factors including age, gender, sheath size, and presence of systemic disease (Class IIa; Level of Evidence B)
- Closure devices “should not be used routinely for the specific purpose of reducing vascular complications” in patients undergoing femoral access PCI (Class III; Level of Evidence B)
- Data on periprocedural and postprocedural complications should be collected either locally or nationally, and reported to the US Food and Drug Administration (Class I; Level of Evidence C)
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 08.10.2010, 12:31
rsp rsp âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 17.12.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 686
Ïîáëàãîäàðèëè 58 ðàç(à) çà 51 ñîîáùåíèé
rsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 08.10.2010, 15:47
Pankov Pankov âíå ôîðóìà ÂÐÀ×
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 08.03.2008
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 136
Ñêàçàë(à) ñïàñèáî: 4
Ïîáëàãîäàðèëè 11 ðàç(à) çà 11 ñîîáùåíèé
Pankov ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò rsp Ïîñìîòðåòü ñîîáùåíèå
Patients who are potential candidates for closure devices during femoral access should undergo a femoral angiogram to identify the sheath-insertion site and other features such as atherosclerosis and calcification to ensure anatomic suitability (Class I; Level of Evidence C)
ÈÌÕÎ, ýòî êëþ÷åâàÿ ôðàçà. Íàäî åå âíåäðèòü â ñîçíàíèå èíòåðâåíòîâ. Åñëè ïðè àíãèîãðàôèè áåäðåííîé àðòåðèè âûÿñíÿåòñÿ, ÷òî ìåñòî ïóíêöèè íåàäåêâàòíîå èëè ñàìà àðòåðèÿ ïîäîçðèòåëüíàÿ, òî ëó÷øå íå óøèâàòü. Ìíîãèå ëåíÿòñÿ äåëàòü àíãèîãðàôèþ, à ïîòîì ïîëó÷àþò îñëîæíåíèÿ è ðóãàþò ïðîèçâîäèòåëåé çà ïëîõèå "óøèâàëêè"
ÇÛ. À âîò èíòåðåñíî, çäåñü åñòü ëþäè, êîòîðûå äåëàëè íåñêîëüêî (ñêàæåì, áîëüøå 2-õ) óøèâàíèé îäíîé ÎÁÀ ó îäíîãî è òîãî æå ïàöèåíòà? Êàê â ïëàíå îòäàëåííûõ ðåçóëüòàòîâ è îñëîæíåíèé? Ìû ïîêà ñòàðàåìñÿ èçáåãàòü...
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 08.10.2010, 17:13
rsp rsp âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 17.12.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 686
Ïîáëàãîäàðèëè 58 ðàç(à) çà 51 ñîîáùåíèé
rsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Pankov Ïîñìîòðåòü ñîîáùåíèå
ÇÛ. À âîò èíòåðåñíî, çäåñü åñòü ëþäè, êîòîðûå äåëàëè íåñêîëüêî (ñêàæåì, áîëüøå 2-õ) óøèâàíèé îäíîé ÎÁÀ ó îäíîãî è òîãî æå ïàöèåíòà? Êàê â ïëàíå îòäàëåííûõ ðåçóëüòàòîâ è îñëîæíåíèé? Ìû ïîêà ñòàðàåìñÿ èçáåãàòü...
ñî "ñòàðêëîóçàìè" ïðîõîäèëè áåç êàêèõ-ëèáî ïðîáëåì è îñëîæíåíèé â ãîñïèòàëüíîì ïåðèîäå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 08.10.2010, 17:36
rsp rsp âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 17.12.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 686
Ïîáëàãîäàðèëè 58 ðàç(à) çà 51 ñîîáùåíèé
rsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårsp ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Pankov Ïîñìîòðåòü ñîîáùåíèå
ÈÌÕÎ, ýòî êëþ÷åâàÿ ôðàçà. Íàäî åå âíåäðèòü â ñîçíàíèå èíòåðâåíòîâ. Åñëè ïðè àíãèîãðàôèè áåäðåííîé àðòåðèè âûÿñíÿåòñÿ, ÷òî ìåñòî ïóíêöèè íåàäåêâàòíîå èëè ñàìà àðòåðèÿ ïîäîçðèòåëüíàÿ, òî ëó÷øå íå óøèâàòü. Ìíîãèå ëåíÿòñÿ äåëàòü àíãèîãðàôèþ, à ïîòîì ïîëó÷àþò îñëîæíåíèÿ è ðóãàþò ïðîèçâîäèòåëåé çà ïëîõèå "óøèâàëêè"
ÿ äóìàþ êóäà âàæíåå ýòî óòâåðæäåíèå:
Öèòàòà:
ACDs should not be used routinely for the specific
purpose of reducing vascular complications in patients
undergoing invasive cardiovascular procedures via the
femoral artery approach (Class III, Level of Evidence
B).
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 08.10.2010, 20:11
Àâàòàð äëÿ GreyWolf
GreyWolf GreyWolf âíå ôîðóìà ÂÐÀ×
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 16.04.2009
Ãîðîä: Ðîññèÿ
Ñîîáùåíèé: 163
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 7 ðàç(à) çà 7 ñîîáùåíèé
GreyWolf ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Pankov Ïîñìîòðåòü ñîîáùåíèå
À âîò èíòåðåñíî, çäåñü åñòü ëþäè, êîòîðûå äåëàëè íåñêîëüêî (ñêàæåì, áîëüøå 2-õ) óøèâàíèé îäíîé ÎÁÀ ó îäíîãî è òîãî æå ïàöèåíòà? Êàê â ïëàíå îòäàëåííûõ ðåçóëüòàòîâ è îñëîæíåíèé? Ìû ïîêà ñòàðàåìñÿ èçáåãàòü...
Àçì åñòü Äâà ðàçà òî÷íî Ñòàðêëîçèë - ïðîáëåì íå áûëî è â îòäàëåííîì âñå ÎÊ. Âîò íàñ÷åò òðåõ ðàç - íå ïîìíþ, ïî-ìîåìó íå áûëî òàêîãî. Ïàðó ðàç ïðè ïîâòîðíûõ èíòåðâåíöèÿõ èãëîé ïîïàäàë ïðÿìî â êëèïñó (ðóêà ïîìíèò òðàåêòîðèþ âêîëà ), ïðèõîäèëîñü ïåðåêàëûâàòü...
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 08.10.2010, 22:49
Àâàòàð äëÿ Abugov
Abugov Abugov âíå ôîðóìà
Ðåíòãåíîõèðóðã
      
 
Ðåãèñòðàöèÿ: 20.02.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,179
Ïîáëàãîäàðèëè 202 ðàç(à) çà 197 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 2
Abugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò GreyWolf Ïîñìîòðåòü ñîîáùåíèå
Àçì åñòü Ïàðó ðàç ïðè ïîâòîðíûõ èíòåðâåíöèÿõ èãëîé ïîïàäàë ïðÿìî â êëèïñó (ðóêà ïîìíèò òðàåêòîðèþ âêîëà )
À ÷¸? Áûëî ïàðó ðàç. ß åù¸ ïóãàëñÿ, ÷òî íà èçâëå÷åíèè èíñòðóìåíòà íåìåäëåííî íàñòóïàåò ãåìîñòàç.
__________________
Àáóãîâ Ñåðãåé Àëåêñàíäðîâè÷.
Ðîññèéñêèé Íàó÷íûé Öåíòð Õèðóðãèè èì. àêàäåìèêà Á.Â. Ïåòðîâñêîãî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 08.10.2010, 22:53
Magi12 Magi12 âíå ôîðóìà Ïîë æåíñêèé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 27.09.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 5
Magi12 *
ñòðàííûé äåâàéñ. ñêîëüêî îí ñòîèò? ÿ ñ óäîâîëüñòâèåì áóäó äåðæàòü ãåìîñòàç õîòü ÷àñ åñëè ìíå áóäóò ïëàòèòü òàêèå äåíüãè Îáåùàþ, îñëîæíåíèé áóäåò ìåíüøå
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 09.10.2010, 14:06
Àâàòàð äëÿ angio
angio angio âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 27.04.2010
Ãîðîä: Ïåòðîçàâîäñê
Ñîîáùåíèé: 949
Ñêàçàë(à) ñïàñèáî: 36
Ïîáëàãîäàðèëè 115 ðàç(à) çà 106 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 1
angio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåangio ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ìíå êàæåòñÿ, ÷òî ýòè äåâàéñû âåñüìà îãðàíè÷åíû â òîì, ÷òî èçáàâëþò îò ñàìûõ, òàê ñêàçàòü, ïðîñòûõ ãåìîñòàçîâ.  òåõ æå ñëó÷àÿõ, êîãäà ýòî óãðîæàåò ñòàòü ïðîáëåìîé: î÷åíü ïîëíûå ïàöèåíòû, ïðîáëåìû ñ ïóíêöèåé, èíòðîäüþñåð 9-10F, ïðîáëåìû ñ ñèñòåìîé ñâåðòûâàíèÿ è åùå ìîæíî ïðèïîíìèòü ìàññó ñèòóàöèé, êîãäà ãåìîñòàç ïðèõîäèòñÿ äåëàòü áåç áîëüøîãî ýíòóçèçèìà - âîò â ýòèõ òî ñëó÷àÿõ âñå ãàäæåòû, êàê íå îáèäíî, ïðîòèâîïîêàçàíû.

À ñäåëàòü ãåìîñòàç "ñòàíäàðòíîìó" ïàöèåíòó íå ñîñòàâëÿåò áîëüøèõ ïðîáëåì íè äëÿ êîãî (êðîìå ëåíèâûõ).
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 09.10.2010, 15:35
Àâàòàð äëÿ Abugov
Abugov Abugov âíå ôîðóìà
Ðåíòãåíîõèðóðã
      
 
Ðåãèñòðàöèÿ: 20.02.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,179
Ïîáëàãîäàðèëè 202 ðàç(à) çà 197 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 2
Abugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò angio Ïîñìîòðåòü ñîîáùåíèå
À ñäåëàòü ãåìîñòàç "ñòàíäàðòíîìó" ïàöèåíòó íå ñîñòàâëÿåò áîëüøèõ ïðîáëåì íè äëÿ êîãî (êðîìå ëåíèâûõ).
Ãåìîñòàç ìîæåò áûòü ïðîáëåìîé âî ìíîãèõ ñëó÷àÿõ. Íàïðèìåð, ó íàñ â ãîä îêîëî 10-òè - 15-òè ëîæíûõ àíåâðèçì. Ìû î÷åíü ðàñ÷èòûâàëè íà óñòðîéñòâà äëÿ çàêðûòèÿ. Ê ñîæàëåíèþ, âî ìíîãîì ðàçî÷àðîâàëèñü. Ñîçäà¸òñÿ âïå÷àòëåíèå, ÷òî ÷èñëî îñëîæíåíèé íå óìåíüøàåòñÿ. Åäèíñòâåííîå ïðåèìóùåñòâî, ñóùåñòâåííî (âïëîòü äî 0) ñîêðàùàåòñÿ âðåìÿ ãåìîñòàçà.
Ïðèÿòíî, ÷òî íàøè îùóùåíèÿ ñîâïàäàþò ñ îæèäàþùèìñÿ êîíñåíñóñîì.
__________________
Àáóãîâ Ñåðãåé Àëåêñàíäðîâè÷.
Ðîññèéñêèé Íàó÷íûé Öåíòð Õèðóðãèè èì. àêàäåìèêà Á.Â. Ïåòðîâñêîãî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 09.10.2010, 20:53
Àâàòàð äëÿ GreyWolf
GreyWolf GreyWolf âíå ôîðóìà ÂÐÀ×
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 16.04.2009
Ãîðîä: Ðîññèÿ
Ñîîáùåíèé: 163
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 7 ðàç(à) çà 7 ñîîáùåíèé
GreyWolf ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Abugov Ïîñìîòðåòü ñîîáùåíèå
Íàïðèìåð, ó íàñ â ãîä îêîëî 10-òè - 15-òè ëîæíûõ àíåâðèçì. Ìû î÷åíü ðàñ÷èòûâàëè íà óñòðîéñòâà äëÿ çàêðûòèÿ. Ê ñîæàëåíèþ, âî ìíîãîì ðàçî÷àðîâàëèñü. Ñîçäà¸òñÿ âïå÷àòëåíèå, ÷òî ÷èñëî îñëîæíåíèé íå óìåíüøàåòñÿ. Åäèíñòâåííîå ïðåèìóùåñòâî, ñóùåñòâåííî (âïëîòü äî 0) ñîêðàùàåòñÿ âðåìÿ ãåìîñòàçà.
10-15 âîîáùå èëè ïîñëå çàøèâàþùèõ óñòðîéñòâ? Íà ìîé âçãëÿä ìíîãîâàòî âîîáùå, à åñëè ïîñëå çàøèâàþùèõ - òî âîïèþùå ìíîãî Ìîãó ñêàçàòü, ÷òî äî ýðû ñòàðêëîçà (äðóãèå òàê è íå îñâîèëè, âñå ýòè íèòêè è ãóáêè ÈÌÕÎ äëÿ õèðóðãîâ) â ãîä ó íàñ áûâàëî 5-6 ëîæíûõ àíåâðèçì. Ñåé÷àñ æå â 90-95% ïîñëå âñåõ PCI øüåì (êëèïèðóåì åñëè óæ ãîâîðèì î ñòàðêëîçå) è ëîæíûõ àíåâðèçì, òüôó òüôó, íå ñòàëî. Ïðàâäà áûëè äðóãèå, òåõíè÷åñêèå ïðîáëåìû... À ñ ïîÿâëåíèåì ÷óäà äåâàéñà Compressar (òèïà ñòðóáöûíû) ïîñëå âñåõ äèàãíîñòèê òîæå, òüôó òüôó, ïðîáëåìû óøëè. Êñòàòè ïðè ýòîì âðåìÿ ãåìîñòàçà óäëèíÿåòñÿ íà ïîðÿäîê (óñïåâàåøü ñäåëàòü áåç ñïåøêè êîðîíàðêó) - ÷òî è ÿâëÿåòñÿ çàëîãîì óñïåõà!
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 09.10.2010, 21:48
Àâàòàð äëÿ Abugov
Abugov Abugov âíå ôîðóìà
Ðåíòãåíîõèðóðã
      
 
Ðåãèñòðàöèÿ: 20.02.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,179
Ïîáëàãîäàðèëè 202 ðàç(à) çà 197 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 2
Abugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò GreyWolf Ïîñìîòðåòü ñîîáùåíèå
Íà ìîé âçãëÿä ìíîãîâàòî âîîáùå, à åñëè ïîñëå çàøèâàþùèõ - òî âîïèþùå ìíîãî
Ðå÷ü èä¸ò ïðî "âîîáùå". Õîøà, åñòü è ïîñëå Ñòàðêëîóçîâ. Âïðî÷åì, ñïàñèáî ÷òî Âû îöåíèëè íàøè òàëàíòû . Êñòàòè, à Âû äåëàåòå Äîïïëåð âñåì, êòî æàëóåòñÿ íà ÷óâñòâî ðàñïèðàíèÿ? Ñ òåõ ïîð, êàê ìû ñòàëè ðàáîòàòü ñ ñîáñòâåííûõ êîåê (à ýòî 90% áîëüíûõ) àíåâðèçìû ñòàëè âûÿâëÿòüñÿ ñóùåñòâåííî ÷àùå. Ìîæåò äåëî â íàñòîðîæåííîñòè? Èëè ÿ äîëæåí ïîâåðèòü â òî, ÷òî íàøà êîìàíäà ïóíêòèðóåò è äåðæèò àðòåðèþ õóæå, ÷åì äðóãèå?
__________________
Àáóãîâ Ñåðãåé Àëåêñàíäðîâè÷.
Ðîññèéñêèé Íàó÷íûé Öåíòð Õèðóðãèè èì. àêàäåìèêà Á.Â. Ïåòðîâñêîãî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 09.10.2010, 22:42
Àâàòàð äëÿ audovichenko
audovichenko audovichenko âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 26.01.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 7,477
Ïîáëàãîäàðèëè 1,531 ðàç(à) çà 1,497 ñîîáùåíèé
audovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaudovichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êàðäèîëîãè, êîòîðûå âåäóò íàøèõ áîëüíûõ, äåëàþò äîïïëåð âñåì, êòî æàëóåòñÿ íà ëþáûå íåïðèÿòíûå îùóùåíèÿ, è âñåì, ó êîãî ðàçìåð ãåìàòîìû ïðåâûøàåò ~ 10-15 êâ. ñì.

GreyWolf, ïî ñóòè - ó íàñ áûëî ÎÄÍÎ òÿæåëîå îñëîæíåíèå ïîñëå StarClose (âñòàëà "áîêîì" è ïðîðåçàëàñü êëèïñà - ïîòðåáîâàëîñü ýêñòðåííîå ïðîòåçèðîâàíèå ÎÁÀ). È îíî áûëî ñâÿçàíî ñ òåì, ÷òî ÿ íåäîîöåíèëà âûÿâëåííóþ ïðè êîíòðîëüíîé àíãèîãðàôèè àòåðîñêëåðîòè÷åñêóþ áëÿøêó â ìåñòå ïóíêöèè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 09.10.2010, 22:57
Àâàòàð äëÿ Abugov
Abugov Abugov âíå ôîðóìà
Ðåíòãåíîõèðóðã
      
 
Ðåãèñòðàöèÿ: 20.02.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,179
Ïîáëàãîäàðèëè 202 ðàç(à) çà 197 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 2
Abugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò audovichenko Ïîñìîòðåòü ñîîáùåíèå
Êàðäèîëîãè, êîòîðûå âåäóò íàøèõ áîëüíûõ, äåëàþò äîïïëåð âñåì, êòî æàëóåòñÿ íà ëþáûå íåïðèÿòíûå îùóùåíèÿ, è âñåì, ó êîãî ðàçìåð ãåìàòîìû ïðåâûøàåò ~ 10-15 êâ. ñì.

GreyWolf, ïî ñóòè - ó íàñ áûëî ÎÄÍÎ òÿæåëîå îñëîæíåíèå ïîñëå StarClose (âñòàëà "áîêîì" è ïðîðåçàëàñü êëèïñà - ïîòðåáîâàëîñü ýêñòðåííîå ïðîòåçèðîâàíèå ÎÁÀ). È îíî áûëî ñâÿçàíî ñ òåì, ÷òî ÿ íåäîîöåíèëà âûÿâëåííóþ ïðè êîíòðîëüíîé àíãèîãðàôèè àòåðîñêëåðîòè÷åñêóþ áëÿøêó â ìåñòå ïóíêöèè.
Ïîíÿë! Çíà÷èò ìû äåéñòâèòåëüíî êîçëû.

Êîììåíòàðèè ê ñîîáùåíèþ:
audovichenko îäîáðèë(à): ñàìîêðèòè÷íî.... Áåé îðäèíàðöåâ!!!
__________________
Àáóãîâ Ñåðãåé Àëåêñàíäðîâè÷.
Ðîññèéñêèé Íàó÷íûé Öåíòð Õèðóðãèè èì. àêàäåìèêà Á.Â. Ïåòðîâñêîãî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 09.10.2010, 23:11
Àâàòàð äëÿ Abugov
Abugov Abugov âíå ôîðóìà
Ðåíòãåíîõèðóðã
      
 
Ðåãèñòðàöèÿ: 20.02.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 2,179
Ïîáëàãîäàðèëè 202 ðàç(à) çà 197 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 2
Abugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAbugov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Abugov Ïîñìîòðåòü ñîîáùåíèå
Ïîíÿë! Çíà÷èò ìû äåéñòâèòåëüíî êîçëû.
Öèòàòà:
audovichenko îäîáðèë(à): ñàìîêðèòè÷íî.... Áåé îðäèíàðöåâ!!!
Âñ¸ òàêè, íåêîòîðóþ èðîíè÷íîñòü ìîèõ ïîñòîâ íåëüçÿ ïîëíîñòüþ èãíîðèðîâàòü...
__________________
Àáóãîâ Ñåðãåé Àëåêñàíäðîâè÷.
Ðîññèéñêèé Íàó÷íûé Öåíòð Õèðóðãèè èì. àêàäåìèêà Á.Â. Ïåòðîâñêîãî.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 13:27.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.